Cargando…
Making pharmaceutical companies report what matters about innovation
1. There is a lack of transparency about the cost of innovation of the pharmaceutical industry even though these costs are claimed to be the major driver for high prices for medicines. 2. This is reflected by annual reports of the major pharmaceutical firms that contain a low number of pages on inno...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292238/ https://www.ncbi.nlm.nih.gov/pubmed/34327736 http://dx.doi.org/10.1111/bcp.14993 |